By a News Reporter-Staff News Editor at Pharma Business Week — According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for “ALLERGYREWARDS PROGRAM” by Diane K. Fry, representing GlaxoSmithKline. This application was made available to the public on June 27, 2014 (see also Trademarks).
The international trademark goods and services class code for this trademark application is 044.
The serial number for this application is 78446244.
The applicant indicates that “Color is not claimed as a feature of the mark.”
As submitted by the applicant, this trademark application relates to the following goods and services: Health information services, namely, providing information on respiratory diseases and disorders and self-management skills for patients with respiratory diseases and/or disorders through global computer networks, and an interactive telephone voice response system; and providing information to the public on the treatment and management of respiratory diseases and disorders by conducting patient screening programs and through television and radio public service announcements.
The owner/registrar information for this application is: Diane K. Fry, GlaxoSmithKline, Five Moore Drive, LGTM, C.3157.3D, Research Triangle Park NC 27709.
Keywords for this news article include: Pharmaceutical Companies, Trademarks, GlaxoSmithKline.
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Trademark Application for “ALLERGYREWARDS PROGRAM” Filed by GlaxoSmithKline
By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for
- 1 min Read
- 07.9.2014
Why have three of the most successful men in Silicon Valley decided to branch out from computing and into nuclear energy?
The Fed model compares the return profile of stocks and US government bonds.
Why distillate crack spreads will likely experience more volatility.
When people talk about interest rates, real estate prices, and cyclical and secular trends, there’s one piece of context they tend not to mention.
The saying that there is no such thing as a free lunch is very much true for Robinhood.
Another Black Swan event is taking place right now. And it’s likely to have a similar effect on uranium prices.
